Deanne Mraz, MD
Procedural Dermatology · Westport, CTNPI 1659542397
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $165,225 of the $249,698 with a category attached, or 66.2%. 33 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2019 at $90,179 and has fallen 88.5% since, to $10,360 in 2025.
Across 448 payments — averaging $557.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$75K
- Merz North America, Inc.$73K
- Endo Pharmaceuticals Inc.$49K
- Galderma Laboratories, L.p.$49K
- Incyte Corporation$669
- Avita Medical Americas, LLC$500
- plus $3K from 27 others
Across 142 payments — averaging $14,654 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.6M
- Endo Pharmaceuticals Inc.$355K
- Merz North America, Inc.$71K
- Avita Medical Americas, LLC$25K
- Pfizer$15K
What the payments were for
- Consulting fees$165,22566%
- Speaking & faculty fees$35,06514%
- Travel & lodging$37,17815%
- Food & beverage$12,1405%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $74,784 |
| Merz North America, Inc. | 78 | $73,106 |
| Endo Pharmaceuticals Inc. | 44 | $48,691 |
| Galderma Laboratories, L.p. | 46 | $48,554 |
| Incyte Corporation | 38 | $669 |
| Avita Medical Americas, LLC | 1 | $500 |
| Aclaris Therapeutics, Inc. | 1 | $500 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $397 |
| Johnson & Johnson | 15 | $348 |
| Sanofi | 14 | $316 |
| Lilly USA, LLC | 6 | $213 |
| Dermira, Inc. | 12 | $180 |
| Novartis | 10 | $178 |
| Amgen | 9 | $166 |
| LEO Pharma Inc. | 13 | $158 |
| Mayne Pharma Commercial LLC | 11 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| Sun Pharmaceutical Industries Inc. | 5 | $102 |
| VYNE Pharmaceuticals Inc. | 4 | $93 |
| Biofrontera Inc. | 5 | $84 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| Almirall LLC | 3 | $59 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Pfizer | 3 | $42 |
| EPI Health, LLC | 1 | $28 |
| Medtronic | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Organon | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Encore Dermatology Inc. | 1 | $18 |
| Revance Therapeutics, Inc. | 1 | $18 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few procedural dermatology providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 18 | $317 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Westport
- Mitchell RossCos Cob$32K
- Robert LangdonGuilford$16K
- Eric ThomasMiddletown$11K
- Lisa KugelmanWest Hartford$3K
- Christopher NorwoodNew Britain$1K
- Mark PenningtonNew Britain$1K
- Michelle MalaneCheshire$666
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.